Skip to content

Multiple Myeloma

Multiple myeloma is a cancer that begins in plasma cells, white blood cells made in the bone marrow. When these cells become cancerous and grow out of control, they can disrupt normal immune and blood-cell functions.

Alkeran

Melphalan

2mg

Melphalan tablets for multiple myeloma and ovarian carcinoma. As an alkylating agent, it damages the DNA of cancer cells to stop them dividing.

From$4.56/ tabletView

Cytoxan

Cyclophosphamide

50mg

Cyclophosphamide tablets for malignant lymphomas and multiple myeloma. It damages the DNA of cancer cells to stop them from multiplying.

From$1.76/ tabletView

Thalix

Thalidomide

50mg

Thalidomide capsules for multiple myeloma and erythema nodosum leprosum. It influences the immune system and blood vessel growth.

From$2.98/ capsuleView

Lenalidomide Capsules

Lenalidomide

10mg

Lenalidomide capsules for multiple myeloma and myelodysplastic syndromes. It is a thalidomide analogue that alters the immune system to attack cancer cells.

From$20.03/ capsuleView

Pomalyst

Pomalidomide

4mg

Pomalidomide capsules for multiple myeloma. This is a newer generation of a drug class that works with the immune system to target myeloma cells.

From$63.90/ capsuleView

Key points

  • Bone marrow may be affected as abnormal cells build up and crowd the space where blood cells are made.
  • Symptoms can include bone pain, tiredness, frequent infections or changes linked to low blood counts.
  • Care may involve medicines, other cancer treatments and monitoring based on how the condition affects the person.

Medicines listed for Multiple Myeloma

The five products listed for multiple myeloma contain Melphalan and Cyclophosphamide, plus thalidomide, lenalidomide and pomalidomide. Melphalan and cyclophosphamide are chemotherapy medicines known as alkylating agents. Thalidomide, lenalidomide and pomalidomide are immunomodulatory medicines that can have roles in managing myeloma.

Further reading